Operating identity
Official terms identify InstaMed Pharmaceuticals, Inc., a Utah corporation, and list a Draper address. Public materials name Tracy Gibbs, PhD as Chief Scientific Officer; leadership and suite details vary across current documents.
← All testing lab reviewsOpen the COA checker
Finished-product issuer · Reviewed 2026-09-03
InstaMed Finished Product Testing review
InstaMed Pharmaceuticals, Inc. in-house testing · Draper, Utah, USA
- Operational read
- Manufacturer QC; not an independent lab
- Operating history
- Corporate trail begins in 2025
- Accreditation
- cGMP facility claimed; proof and scope unresolved
Legitimacy review
Is InstaMed Finished Product Testing legit?
InstaMed is an identifiable Utah product company with named scientific leadership and internal QC claims. Its certificates should not be marketed as independent third-party testing unless the performing laboratory is separately named and verified.
Operating history and strongest evidence
Named Utah corporation, product and policy pages, fixed address, named scientific officer, and a documented internal testing program.
Accreditation scope
The company says products are made in a certified cGMP facility but does not publish the operator, certifying body, certificate number, or scope. No ISO/IEC 17025 laboratory record was found.
Methods and intake
Official materials describe raw-peptide verification, finished-product quality control, stability, potency, and purity testing for the company's own products, not open consumer sample testing.
Public service record
No reliable independent review corpus for this exact company surfaced; similarly named healthcare-payment company reviews are unrelated.
Important limits
Independent laboratory identity, cGMP certificate and scope, third-party testing provider, suite address, and current leadership need clarification. Internal manufacturer testing is a different evidence category from independent third-party laboratory work.
COA verification
Can I check a InstaMed Finished Product Testing COA?
Document review only; no official public certificate-verification workflow is established.
- Official destination
- Brand site or contact route only; no exact official certificate permalink or public search is established.
- What you need
- Lot number
- Exact-link rule
- No reusable public-link rule is confirmed.
- Stored identifiers complete?
- No
- Record-specific links?
- No
- Identifier copyable?
- No
Identifiers on the certificate
- Lot numberThe header field labeled Lot Number.
Result handling
How each verification state is reported
Exact match
Use only when the official destination returns the same identifier and the material certificate fields agree.
No match
Use only after a functioning official lookup explicitly returns no record for the submitted identifier.
Conflict
Use when the official destination resolves the identifier but returns a different report, product, batch, or other material identity field.
Portal unavailable
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Unsupported lab
InstaMed is reference-only in the fixed checker and should be labeled a document-only finished-product issuer unless an independent laboratory is named and verified.
Unresolved
Use when the issuer identity, required identifier, or official workflow cannot be established from the available evidence.
Certificate structure
Multi-page and multi-panel reports
Multi-page
The five retained examples are single-page vendor-hosted images; preserve all pages if later reports expand beyond one page.
Multi-panel
Keep appearance, active-content, heavy-metal, and microbial sections separate. Missing purity, sterility, or endotoxin panels are coverage gaps, not proof of failure.
Evidence boundaries
What the record does—and does not—connect
- Certificate identity
- A certificate file, its printed identifiers, and its retained fingerprint identify that document only.
- Issuer verification
- No independent issuer lookup is available; the current evidence shows a vendor-hosted copy of an InstaMed-branded document only.
- Tested sample
- The report describes only the sample identified on the certificate; it does not establish how the sample was selected.
- Product matching
- Match a report to a product only when the compound, strength or formulation, and lot or batch agree exactly.
- Physical-vial custody
- Physical-vial custody is unknown unless a documented chain connects the tested sample to the specific vial in hand.
Review receipts
Records and discrepancies checked
Representative records
- L1166BioLongevity-hosted BPC-157 oral-strip certificate dated July 17, 2025; reports 0.56 mg/strip by LC-MS/MS plus heavy-metal and microbial panels, but no public verifier identifier.
- L1162-L1165Four additional BioLongevity-hosted finished-product images cover CJC-1295, PT-141, GHK-Cu, and Thymosin Alpha-1; all remain outside the fixed checker and issuer-unresolved.
Concrete discrepancies
- The fixed checker shows zero InstaMed certificates, while the expanded vendor archive retains five BioLongevity-hosted InstaMed finished-product files.
- The expanded archive stores no issuer label, report identifier, official laboratory link, or public verification credential for those five files.
- The registry label implies testing, but current primary evidence more clearly supports a finished-product manufacturer or document issuer classification.
- No independently attributable official issuer domain was established; instamedstrips.com carries an independent-distributor notice.
Public search record
What current search results cover
Search results are dominated by the InstaMed product brand and distributors. One third-party COA audit discusses lot L1166, but no independent laboratory portal or established lab-review corpus surfaced.
Sources
Evidence used for this review
- InstaMedbrand_or_distributor
- InstaMed peptide education and processbrand_or_distributor
- BPC-157 InstaMed finished-product COA auditsecondary_review
- InstaMed termsofficial
- InstaMed scienceofficial_method
Reusable integration rule: Classify future InstaMed material as finished-product documentation, capture the lot and every reported panel, and require a separately named performing lab before claiming third-party laboratory verification.
Check the document